Nuromol advertising triggers complaints
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Australia’s Therapeutic Goods Administration is assessing number of complaints against advertising for Reckitt Benckiser’s (RB’s) Nuromol paracetamol and ibuprofen combination pain killer.